Contact
searchSearch
HMP Global

Skin of Color Topic Center

Featured

News
Tralokinumab Demonstrates Sustained Real-World Effectiveness in Patients With Skin of Color and Atopic Dermatitis
04/01/2026
Riya Gandhi, MA
TRACE study data show consistent improvements in disease severity and quality of life over 12 months in an underrepresented population.
TRACE study data show consistent improvements in disease severity and quality of life over 12 months in an underrepresented population.
TRACE study data show consistent...
04/01/2026
The Dermatologist
News
Immune Checkpoint Inhibitor–Associated Vitiligo Shows Earlier Onset in Melanoma and Greater Severity With Combination Therapy
03/31/2026
Riya Gandhi, MA
Single-center cohort highlights differences in timing and extent of vitiligo based on cancer type and treatment regimen.
Single-center cohort highlights differences in timing and extent of vitiligo based on cancer type and treatment regimen.
Single-center cohort highlights...
03/31/2026
The Dermatologist
News
Vitiligo Associated With Increased Cardiometabolic Risk in Large Retrospective Cohort Analysis
03/30/2026
Riya Gandhi, MA
Propensity-matched data show higher rates of diabetes, hypertension, and metabolic syndrome in adults with vitiligo.
Propensity-matched data show higher rates of diabetes, hypertension, and metabolic syndrome in adults with vitiligo.
Propensity-matched data show...
03/30/2026
The Dermatologist
Asempa
Clinical Insights
Advancing Inclusive Outcome Measures in Dermatology
03/02/2026
Hermon Feron, BA; Victoria Garfinkel, BSA
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr Asempa and Dr Alexis emphasized that without inclusive trial design and culturally responsive terminology, we risk biased severity assessments and inequitable treatment decisions.
In a recent panel discussion, Dr...
03/02/2026
The Dermatologist
Nada Elbuluk
Podcasts
Inflammatory Skin Conditions in Skin of Color
01/22/2025
Nada Elbuluk, MD, MSc
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the...
01/22/2025
The Dermatologist
SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
Janiene Luke, MD
Videos
Insights on Skin of Color: Pigmentary Disorders
01/28/2022
Janiene Luke, MD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society...
01/28/2022
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist

Expert Insights

Nada Elbuluk
Podcasts
Inflammatory Skin Conditions in Skin of Color
01/22/2025
Nada Elbuluk, MD, MSc
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the unique diagnostic and treatment challenges for inflammatory skin conditions in patients with skin of color.
Dr Nada Elbuluk highlights the...
01/22/2025
The Dermatologist
Janiene Luke, MD
Videos
Insights on Skin of Color: Pigmentary Disorders
01/28/2022
Janiene Luke, MD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society Media Day, Janiene Luke, MD, held a presentation on pigmentary disorders alongside her colleague Seemal R. Desai, MD, FAAD
During Skin of Color Society...
01/28/2022
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
DR
Videos
Notable Results From the Trials of Ruxolitinib Cream for Vitiligo
01/14/2022
David Rosmarin, MD
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights the notable results and differences between the phase 2 and phase 3 trials studying ruxolitinib cream for repigmenting vitiligo.
David Rosmarin, MD, highlights...
01/14/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Feature Story
Recognizing the Impact of Diseases in Skin of Color
07/16/2021
Lauren Mateja
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker skin types can have a profound effect on quality of life. Increased education can help mitigate these effects by recognizing...
Dermatologic disease in darker...
07/16/2021
The Dermatologist
Q&As
Dr Seemal R. Desai on The Skin Bleaching Epidemic
04/25/2021
During the What’s New in Skin of Color session at AAD VMX 2021, Seemal R. Desai, MD, FAAD discussed the skin bleaching epidemic, a growing issue seen in patients of color.
During the What’s New in Skin of Color session at AAD VMX 2021, Seemal R. Desai, MD, FAAD discussed the skin bleaching epidemic, a growing issue seen in patients of color.
During the What’s New in Skin of...
04/25/2021
The Dermatologist
Feature Story
Tackling Racism in Dermatology: From Literature to Practice
11/16/2020
Lauren Mateja
The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know...
The dearth of clinical images of the cutaneous manifestations of COVID-19 in higher Fitzpatrick skin types represents a larger problem: how can dermatology diagnose diseases in darker skin if clinicians do not know...
The...
11/16/2020
The Dermatologist
Cover Story
Seeing the Spectrum: Including and Embracing Skin of Color Education in Everyday Dermatologic Practice
08/13/2020
Taylor Jamerson
Recent anti-racism movements have accentuated the longstanding need for increased training on darker skin types. The Skin of Color Society and its members are making strides in helping all dermatologists improve their knowledge.
Recent anti-racism movements have accentuated the longstanding need for increased training on darker skin types. The Skin of Color Society and its members are making strides in helping all dermatologists improve their knowledge.
Recent anti-racism movements...
08/13/2020
The Dermatologist
Feature Story
Developing a Care Program for Neglected Patient Groups: Oculocutaneous Albinism
06/11/2020
Ellen Anshelevich, BA; Victoria Williams, MD
Oculocutaneous albinism (OCA) is a rare genetic disorder that all physicians learn about in medical school, but it may never again cross your mind as a practicing dermatologist in the United States. However, in...
Oculocutaneous albinism (OCA) is a rare genetic disorder that all physicians learn about in medical school, but it may never again cross your mind as a practicing dermatologist in the United States. However, in...
...
06/11/2020
The Dermatologist
Heberton
Videos
Managing EGFR Skin Toxicities
04/01/2026
Riya Gandhi, MA
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the...
04/01/2026
The Dermatologist
Amy paller
Videos
Disease Biology and Early Recognition in Atopic Dermatitis
04/01/2026
Amy S. Paller, MD, MS; Riya Gandhi, MA
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how recognizing pediatric atopic dermatitis as a type 2 inflammatory disease has transformed early treatment strategies, enabling safer and more proactive use of targeted therapies.
Dr Amy Paller discusses how...
04/01/2026
The Dermatologist
Joseph F. Merola, MD, MMSc, and Colby Evans, MD
Videos
Autoimmune Serologies in Dermatology
04/01/2026
Riya Gandhi, MA
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how...
04/01/2026
The Dermatologist
Melissa Mauskar, MD
Videos
Practical Pearls of Vulvar Dermatoses
04/01/2026
Riya Gandhi, MA
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses...
04/01/2026
The Dermatologist
Guttman
Videos
Chronic Hand Eczema: Pathways and Emerging Therapies
04/01/2026
Riya Gandhi, MA
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Dr Emma Guttman explains how...
04/01/2026
The Dermatologist
Elman
Videos
Baseline Screening and Monitoring for Biologics and Small Molecules
04/01/2026
Scott Andrew Elman, MD, FAAD; Riya Gandhi, MA
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Are dermatologists overtesting...
04/01/2026
The Dermatologist
brad glick
Videos
Oral Therapies in Psoriasis
04/01/2026
Riya Gandhi, MA
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses...
04/01/2026
The Dermatologist
Videos
Hidradenitis Suppurativa: Early Recognition, IL-17 Targeted Therapies, and Multidisciplinary Care
04/01/2026
Riya Gandhi, MA
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how...
04/01/2026
The Dermatologist
Asempa
Videos
Improving Dermatology Measures for Skin of Color and Underrepresented Groups
04/01/2026
Riya Gandhi, MA
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
This interview examines the...
04/01/2026
The Dermatologist
Orgill
Videos
Mohs Reconstruction Collaboration
04/01/2026
Riya Gandhi, MA
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when...
04/01/2026
The Dermatologist

News

SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
News
Ethnic Differences in Photoaging to Guide Future Developments
04/25/2021
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection...
04/25/2021
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
cover March 2026

Current Issue

March 2026
Volume 34
Issue 2
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

SOC
News
Shifting the Care Paradigm for Individuals With Skin of Color
06/17/2024
Jessica Garlewicz
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology research and clinical practices have overlooked critical aspects of care for individuals with skin of color.
Historically, dermatology...
06/17/2024
The Dermatologist
News
Vitiligo Point Prevalence in Children and Adolescents in the United States
01/17/2023
Jessica Garlewicz
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online, population-based survey made up of a nationally representative sample of individuals.
Researchers conducted an online,...
01/17/2023
The Dermatologist
News
Post-Surgical Aesthetic Discomfort in Patients of Color
03/08/2022
Jessica Garlewicz
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic discomfort, particularly in bilateral lesions and a fear of breast cancer.
Patients were seen for aesthetic...
03/08/2022
The Dermatologist
News
Skin Hyperpigmentation Index is a Reliable Method for Measuring SH
02/03/2022
Jessica Garlewicz
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain evidence of the reliability and validity of the SHI compared to the physician global assessment score.
Researchers aimed to gain...
02/03/2022
The Dermatologist
News
Ethnic Differences in Photoaging to Guide Future Developments
04/25/2021
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection to prevent photoaging is well known but another factor contributing to skin aging is often overlooked.
The importance of sun protection...
04/25/2021
The Dermatologist
psoriasis0
News
Altered Lysine Crotonylation Identified in Psoriatic Skin
03/19/2026
Jessica Garlewicz
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a post-translational modification previously studied in oncology, may play a role in psoriasis pathogenesis, according to a translational study comparing protein modification profiles in lesional and non-lesional skin.
Lysine crotonylation, a...
03/19/2026
The Dermatologist
FDA Alerts
FDA Approves Icotyde (icotrokinra) for the Treatment of Moderate-To-Severe Plaque Psoriasis in Adults and Pediatric Patients
03/18/2026
Jessica Garlewicz
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug Administration approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients aged 12 years and older.
The US Food and Drug...
03/18/2026
The Dermatologist
FDA Alerts
FDA Approves Cosentyx for the Treatment of Pediatric Patients Aged 12 Years and Older With Moderate-To-Severe Hidradenitis Suppurativa
03/17/2026
Jessica Garlewicz
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug Administration approved Cosentyx for the treatment of pediatric patients aged 12 years and older with moderate-to-severe hidradenitis suppurativa.
The US Food and Drug...
03/17/2026
The Dermatologist
atopic dermatitis
News
Mixed Associations Between Socioeconomic Status and Pediatric Atopic Dermatitis Highlight Research Gaps
03/11/2026
Jessica Garlewicz
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to influence pediatric atopic dermatitis, but the direction and strength of the association remain unclear.
Socioeconomic status appears to...
03/11/2026
The Dermatologist
FDA Alerts
FDA Approves Sotyktu for the Treatment of Adults with Active Psoriatic Arthritis
03/10/2026
Jessica Garlewicz
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food and Drug Administration approved Sotyktu (deucravacitinib) for the treatment of adults with active psoriatic arthritis.
On March 6, 2026, the US Food...
03/10/2026
The Dermatologist
psoriasis
News
Biologic Therapy Improves Psychological Well-Being and Quality of Life in Psoriasis
03/03/2026
Jessica Garlewicz
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for moderate-to-severe plaque psoriasis was associated with marked improvements in psychological distress and quality of life in a real-world clinical setting.
Biologic therapy for...
03/03/2026
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use